Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Summary: Histopathology of gynaecological cancers

  • Primary ovarian tumours consist of GCTs, SCSTs and epithelial tumours
  • The majority of GCTs are benign, and the majority of SCSTs are benign or of low malignant potential
  • Tubo-ovarian carcinomas constitute the majority of malignant tumours at this anatomical site, of which HGSC is the most common type
  • The majority of malignant uterine tumours are carcinomas, which are grossly divided into endometrioid and non-endometrioid
  • TCGA classification has prognostic relevance in uterine cancer, and p53, MMR and POLE are surrogate markers for this classification
  • The most common uterine sarcomas are LMS and ESS, the latter divided into low-grade and high-grade entities, each with unique fusion genes
  • Uterine cervical carcinomas are classified as SCC, adenocarcinoma and neuroendocrine carcinoma
  • Cervical adenocarcinomas are divided into HPV-associated and HPV-independent tumours
  • The majority of malignant vulvar tumours are VSCCs, which are divided into HPV-associated and HPV-independent tumours
  • Genetic predisposition for gynaecological tumours includes BRCA1/2 mutations in HGSC and MMR gene mutations (Lynch syndrome) in uterine corpus carcinoma, and less often in tubo-ovarian carcinoma

Further Reading

  • Kurman RJ, Ellenson LH, Ronnett BM (Eds). Blaustein's Pathology of the Female Genital Tract, 7th edition. New York: Springer Nature, 2019.
  • Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin 2019; 69:280–304.
  • Lu KH, Broaddus RR. Endometrial cancer. N Engl J Med 2020; 383:2053–2064.
  • Prat J, D'Angelo E, Espinosa I. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics. Hum Pathol 2018; 80:11–27.
  • Singh N, Gilks CB. Vulval squamous cell carcinoma and its precursors. Histopathology 2020; 76:128–138.
  • Soslow RA, Tornos C, Park KJ, et al. Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the International Society of Gynecological Pathologists. Int J Gynecol Pathol 2019; 38 Suppl 1 (Iss 1 Suppl 1):S64–S74.
  • Stolnicu S, Soslow RA. Squamous and glandular epithelial tumors of the cervix: a pragmatical review emphasizing emerging issues in classification, diagnosis, and staging. Surg Pathol Clin 2022; 15:369–388.
  • WHO Classification of Tumours Editorial Board. Female Genital Tumours. WHO Classification of Tumours, 5th edition, Volume 4. Lyon, France: IARC, 2020.
Vulvar tumours

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.